Triaza-spiropiperidine derivatives for use as glyt-1 inhibitors in the treatment of neurological and neuropsychiatric disorders

Details for Australian Patent Application No. 2004283843 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Ceccarelli, Simona Maria; Stalder, Henri; Pinard, Emmanuel

Agent Spruson & Ferguson

Pub. Number AU-B-2004283843

PCT Pub. Number WO2005/040166

Priority 03024415.6 23.10.03 EP

Filing date 14 October 2004

Wipo publication date 6 May 2005

Acceptance publication date 22 April 2010

International Classifications

C07D 471/10 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/040166 Priority application(s): WO2005/040166

22 April 2010 Application Accepted

  Published as AU-B-2004283843

19 August 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004283844-Aminoalkanol derivatives

2004283842-CCR3 receptor antagonists